BeStock  
Stocks › Biotechnology › HRMY

Harmony Biosciences HRMY

US equityMarket cap rank #2704Biotechnology
$32.59 −$0.39 (-1.18%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.59 0.00%
Open$32.68
Prev close$32.98
Day range$32.51 – $33.43
Volume582.6K
Market cap$1.91B
P/E (TTM)10.8
Dividend yield–

HRMY Stock News

Headlines matching Harmony Biosciences or the HRMY ticker, most recent first.

  • Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $51Market news · 26 Sep 2026 · Direct mention
  • Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $50Market news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Harmony Biosciences(HRMY.US), With a Forecast Between $30 to $55Market news · 5 Aug 2026 · Direct mention
  • Deutsche Bank Maintains Harmony Biosciences(HRMY.US) With Hold Rating, Raises Target Price to $39 PositiveMarket news · 5 Aug 2026 · Direct mention
  • Wolfe Research Initiates Harmony Biosciences(HRMY.US) With Buy Rating, Announces Target Price $60Market news · 26 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $55Market news · 12 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $51 PositiveMarket news · 31 Jul 2026 · Direct mention
  • Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $50Market news · 28 Jul 2026 · Direct mention
  • Goldman Sachs Upgrades Harmony Biosciences(HRMY.US) to Hold Rating, Raises Target Price to $37 PositiveMarket news · 17 Jul 2026 · Direct mention
  • Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $45Market news · 16 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL)TipRanks · 16 Jul 2026 · Direct mention
  • Deutsche Bank Maintains Harmony Biosciences(HRMY.US) With Hold Rating, Raises Target Price to $36 PositiveMarket news · 30 Jun 2026 · Direct mention
  • Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $45 PositiveMarket news · 8 May 2026 · Direct mention
  • Piper Sandler Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Cuts Target Price to $46 NegativeMarket news · 22 Apr 2026 · Direct mention
  • Oppenheimer Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $72 PositiveMarket news · 22 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on HRMY.

Sign in to join the discussion.

Scroll to Top